tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Affimed downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyAffimed downgraded to Neutral from Buy at H.C. Wainwright
4M ago
Affimed’s Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
Premium
Ratings
Affimed’s Insolvency Proceedings and Liquidity Crisis Lead to Hold Rating
4M ago
Affimed downgraded to Equal Weight at Wells after insolvency filing
Premium
The Fly
Affimed downgraded to Equal Weight at Wells after insolvency filing
4M ago
Affimed announces filing for opeing of insolvency proceedings
PremiumThe FlyAffimed announces filing for opeing of insolvency proceedings
4M ago
Affimed’s Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
Premium
Ratings
Affimed’s Financial and Strategic Challenges Lead to Hold Rating Amid Funding and Regulatory Concerns
4M ago
Affimed downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Affimed downgraded to Market Perform from Outperform at Leerink
4M ago
Affimed price target lowered to $11 from $15 at Wells Fargo
PremiumThe FlyAffimed price target lowered to $11 from $15 at Wells Fargo
9M ago
Affimed price target lowered to $7 from $10 at H.C. Wainwright
Premium
The Fly
Affimed price target lowered to $7 from $10 at H.C. Wainwright
9M ago
Affimed’s Promising Clinical Update on NSCLC Treatment
Premium
Company Announcements
Affimed’s Promising Clinical Update on NSCLC Treatment
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100